Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals.
We aimed to describe the incidence of liver related events (LRE) in a population of hepatitis C compensated advanced chronic liver disease (cACLD) patients who achieved sustained virological response (SVR) after direct-acting antiviral (DAA) therapy and identify non-invasive parameters to predict the occurrence of LRE. This two-center prospective study included 572 cACLD patients who had been treated with DAA and had achieved SVR. Patients had liver stiffness measurement (LSM) ≥10 kPa at baseline and had never decompensated (Child Pugh class A). Laboratory work up and LSM was performed at baseline and at one year of follow up (FU). The median follow-up was 2.8 years during which 32 patients (5.6%) presented LRE. The incidence rate (IR) of portal hypertension related decompensation was 0.34/100 patient-years. These patients had all baseline LSM>20 kPa and in 4 out of 5 LSM did not improve during FU. HCC occurred in 25 patients (IR 1.5/100 patient-years). Albumin levels at FU (HR 0.08, 95% CI: 0.02-0.25) and LSM <10 kPa at FU (HR 0.33, 95% CI: 0.11-0.96) were independently associated with the risk of HCC. Combining both predictors we identified two different risk groups of HCC occurrence, being those with LSM ≥20 kPa at FU and with LSM between 10-20 kPa and albumin levels <4.4 g/dL the ones with the highest risk (IR ≥1.9/100 patient-years). Visual nomograms predicting HCC risk during time based on LSM and albumin at one year of FU were constructed. In hepatitis C cACLD patients who have achieved SVR with DAA, HCC is the most frequent LRE. Both albumin levels and LSM during FU are useful to stratify the risk of presenting HCC. The new oral antivirals can cure chronic hepatitis C infection, however patients with advanced chronic liver disease are still at risk of presenting complications. The most frequent complication after oral antivirals therapy in asymptomatic patients with advanced chronic liver disease was liver cancer. The use of simple parameters such liver stiffness and albumin levels after treatment can help to identify patients with different risks of presenting liver cancer.